EFFECTS OF INCREASED VEDOLIZUMAB DOSING FREQUENCY ON DISEASE ACTIVITY IN ULCERATIVE COLITIS AND CROHN’S DISEASE

Bruce E. Sands  1     Severine Vermeire  2     Serap Sankoh  3     Catherine Milch  3    
1 Icahn School Of Medicine At Mount Sinai, New York, United States
2 University Hospital Gasthuisberg, Leuven, Belgium
3 Takeda Pharmaceuticals International Co., Cambridge, United States

Conference
UEG Week 2014

Citation
United European Gastroenterology Journal; 2014: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing